[APLS] YoY Annual Result on 31-Dec-2013 [#FY]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
30-Dec-2013
Financial Year
2013
Quarter
31-Dec-2013 [#FY]
Profit Trend
YoY-
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -304,707 -127,502 -51,006 -27,125 -46,516 -11,232 -3,962 106.15%
Tax 5,109 -533 251 -27,282 -26,537 -443 0 -
NP -309,816 -127,502 -51,006 -27,125 -46,516 -10,788 -3,962 106.72%
Tax Rate - - - - - - - -
Total Cost 309,816 127,502 51,006 27,125 46,516 10,788 3,962 106.72%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -4.98 -2.34 -3.68 -1.50 -2.57 -0.60 -0.22 68.15%
EPS Diluted -4.98 -2.34 -3.68 -1.50 -2.57 -0.60 -0.22 68.15%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.